• EN - English
  • FR - français
Parliamentary question - E-000355/2024Parliamentary question

Lobbies calling for mRNA vaccines not to be classified as gene therapy

Question for written answer  E-000355/2024
to the Commission
Rule 138
Virginie Joron (ID)

On 17 January 2024, BioNTech and Moderna lobbyists hosted a lunch in the European Parliament with Members[1] to discuss the forthcoming revision of the pharmaceutical legislation.

Their main objective was to change the legislation’s definition of ‘gene therapy’. At present, mRNA vaccines (like the COVID-19 vaccine) are to be classified as gene therapy. However, they felt that only products that modified the genome should be classified as gene therapy.


Last updated: 9 February 2024
Legal notice - Privacy policy